Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GLP-1 receptor agonist medications were originally developed to treat type 2 diabetes and were found to cause weight loss while also decreasing the risk of cardiovascular events such as heart attacks and strokes in people with diabetes
Mitochondrial ROS are increased under hypoxia, ischemia/reperfusion injury, chemical stress, drug treatment, and under many pathophysiological conditions (Srinivasan and Avadhani, 2012)
For a full scientific profile of MT-1 (Afamelanotide), including its EMA regulatory history and MC1R-specific pharmacology, see our dedicated MT1 10mg research peptide guide
What About TB-500
US$ 23.78
US$ 20.90
US$ 22.72
US$ 23.24
